553 results on '"Maria, Ruggero"'
Search Results
2. Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres
3. The 1+Million Genomes Minimal Dataset for Cancer
4. Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
5. From theory to practice: Implementing next-generation sequencing and public health genomics in healthcare systems
6. Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients
7. L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fibrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients
8. Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems
9. Apoptotic cell death in disease—Current understanding of the NCCD 2023
10. Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution
11. Exploiting bioactive natural products of marine origin: Evaluation of the meroterpenoid metachromin V as a novel potential therapeutic drug for colorectal cancer
12. Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
13. Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51
14. Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer
15. An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile
16. A real-time integrated framework to support clinical decision making for covid-19 patients
17. Oncolytic virus and CAR-T cell therapy in solid tumors.
18. KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy
19. CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin
20. Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51
21. Advancements in 3D In Vitro Models for Colorectal Cancer.
22. Uracil‐ and Pyridine‐Containing HDAC Inhibitors Displayed Cytotoxicity in Colorectal and Glioblastoma Cancer Stem Cells.
23. The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial
24. Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery
25. Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer
26. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant
27. Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma
28. Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer
29. Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study
30. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection
31. Cancer stem cells: at the forefront of personalized medicine and immunotherapy
32. A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave?
33. A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer
34. HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome
35. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
36. Requirement for GD3 Ganglioside in CD95- and Ceramide-Induced Apoptosis
37. Potential Involvement of Fas and Its Ligand in the Pathogenesis of Hashimoto's Thyroiditis
38. Presurgical window of opportunity trial design as a platform for testing anticancer drugs: Pros, cons and a focus on breast cancer
39. Hippo pathway and breast cancer stem cells
40. A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells
41. A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors
42. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance
43. Zika virus infection induces MiR34c expression in glioblastoma stem cells: new perspectives for brain tumor treatments
44. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases
45. The autophagic protein FYCO1 controls TNFRSF10/TRAIL receptor induced apoptosis and is inactivated by CASP8 (caspase 8).
46. Androgen receptor and antiandrogen therapy in male breast cancer
47. Renal cancer: new models and approach for personalizing therapy
48. Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer
49. Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer
50. Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.